Theme

Emerging therapeutic platforms

Novel therapeutics treating diseases through the use of live cells and genetic material.
Emerging therapeutic platforms

Emerging therapeutic platforms

Emerging field of therapeutics, cell, and gene therapies can be impactful in diseases currently deemed untreatable. Opportunities include discovery and development of new drug candidates, platform services to support R&D and manufacturing, as well as the manufacturing and supply chain infrastructure to support large scale production of these treatments.

Emerging therapeutic platforms

Our approach

Our approach is rooted in a deep understanding of the healthcare industry and a commitment to making a positive impact. We are currently focused on investing in companies that:

Significantly enhance patient outcomes

We support companies that are dedicated to advancing research and development in healthcare, paving the way for development of new healthcare products, treatments, therapies and cures.

Involve a substantial ‘Make-in-India’ component

We seek out companies which are focused on manufacturing top-notch healthcare products for domestic as well as global markets.

Harness technology to augment healthcare delivery

We intend to invest in companies that utilize advanced technologies like artificial intelligence, machine learning and data analytics to improve efficiency of healthcare delivery and outcome. In particular, we are keen on digital health concepts which focus on developing therapeutic ideas, analyzing medical data, and identifying patterns.

Related partnerships

Company
Sector(S)
Investment Stage
Company Status
Growth
Private
Healthcare

Early
Private
Healthcare

US

Perspectives

What we’re reading.